title: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?
authors.affiliation: 1 KNCV (Royal Netherlands Anti-TB Association) Tuberculosis Foundation The Hague, the Netherlands.
authors.forename: Agnes
authors.initials: A
authors.lastname: Gebhard
authors.affiliation: 1 KNCV (Royal Netherlands Anti-TB Association) Tuberculosis Foundation The Hague, the Netherlands.|2 Department of Global Health, Academic Medical Center Amsterdam, the Netherlands and.|3 Amsterdam Institute for Global Health and Development Amsterdam, the Netherlands.
authors.forename: Susan
authors.initials: S
authors.lastname: van den Hof
authors.affiliation: 1 KNCV (Royal Netherlands Anti-TB Association) Tuberculosis Foundation The Hague, the Netherlands.|2 Department of Global Health, Academic Medical Center Amsterdam, the Netherlands and.|3 Amsterdam Institute for Global Health and Development Amsterdam, the Netherlands.
authors.forename: Frank
authors.initials: F
authors.lastname: Cobelens
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents